Educational atlas

Soluble activin type IIB receptor fusion protein designed to trap myostatin/activin ligands and increase muscle mass; clinical development halted after safety signals.

Dilute acetic acid solution used to reconstitute hydrophobic or poorly water-soluble peptides that do not dissolve well in plain bacteriostatic water.

Full-length adrenocorticotropic hormone peptide used in endocrine and stress-axis research; parent pathway for several nootropic ACTH analogs.

Designer Semax analog featuring terminal modifications (acetylation ± adamantane-related) intended to improve stability and BBB penetration; almost no independent peer-reviewed identity.

Experimental peptidomimetic that targets prohibitin on white adipose vasculature, designed to trigger apoptosis of fat-blood-supply cells and reduce fat mass in animal models.

Cell-permeable AMPK-activating nucleoside analog famously studied as an exercise mimetic in sedentary mice; WADA-prohibited.

Modified hGH fragment studied for fat metabolism without classic GH growth effects.

Non-hematopoietic EPO-derived peptide studied for neuropathy and tissue-protective inflammation control.

Single-chain H2-relaxin B-chain derivative that preferentially activates antifibrotic RXFP1–pERK signaling; retains organ antifibrosis benefits of serelaxin without full cAMP profile in key models.

Sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative — standard diluent for multi-dose reconstitution of lyophilized research peptides.

Synthetic gastric pentadecapeptide studied for tissue repair, gut integrity, and soft-tissue recovery.

Long-acting amylin analog studied alone and with semaglutide (CagriSema) for obesity.

Fixed dual research blend combining amylin analog cagrilintide with GLP-1 agonist semaglutide — mirrors the highly effective investigational obesity combination approach.

Khavinson-class tetrapeptide bioregulator (Ala-Glu-Asp-Arg) studied for cardiomyocyte gene regulation, anti-apoptosis, and cardiac tissue support in Russian bioregulator literature.

GHRH analog that stimulates natural growth-hormone pulses; used with GHRPs for body composition and recovery goals.

The default growth-hormone peptide stack in biohacking: GHRH analog + selective GHRP for physiologic pulses.

Long-acting GHRH analogue form of CJC-1295 using Drug Affinity Complex for multi-day GH/IGF-1 elevation research framing.

Khavinson tetrapeptide bioregulator (Ala-Glu-Asp-Pro) developed as a cerebral-cortex-targeted short peptide for neuroprotection and cortical gene regulation research.

Khavinson immune/thymus-focused short peptide bioregulator commonly cited as Glu-Asp-Pro (EDP), positioned as a synthetic counterpart within the thymic bioregulator family alongside Thymalin.

Extremely potent natural mu-opioid heptapeptide from South American frog skin; research and forensic interest due to analgesic potency far exceeding morphine.

Potent procognitive angiotensin IV–related compound; extremely experimental with safety unknowns.

Neuropeptide historically studied for sleep induction and stress modulation; mixed evidence.

Synthetic tetrapeptide from Russian bioregulator research, claimed to influence telomerase and circadian rhythms.

Myostatin-pathway related protein/peptide product marketed for extreme muscle growth; high risk, poor quality control.

Synthetic D-retro-inverso peptide designed to disrupt FOXO4–p53 interaction, studied as a senolytic that selectively clears senescent cells in preclinical models.

Endogenous negative regulator of skeletal muscle growth; catalog material is typically for assay/research reference rather than use as a drug.

Naturally occurring copper-binding tripeptide popular for skin remodeling, hair, and regenerative aesthetics.

Potent GH-releasing peptide; stronger hunger and prolactin/cortisol effects than Ipamorelin.

Early GHRP known for intense appetite stimulation; used when hunger and GH pulse are both desired.

Popular aesthetics-oriented trio combining copper peptide remodeling with dual recovery peptides.

Endogenous peptide hormone raising blood glucose; medical rescue drug and component of dual/triple agonist design.

Tripeptide antioxidant (Glu-Cys-Gly) central to cellular redox defense; used IV in clinics and discussed for skin brightening and detox narratives.

Synthetic gonadotropin-releasing hormone used to stimulate pituitary LH/FSH release; research and diagnostic endocrine applications.

Glycoprotein hormone used in fertility and TRT adjunct settings; endocrine staple in men’s health clinics.

Very potent GHRP with notable GH output but higher desensitization and cortisol/prolactin risk.

Recombinant human growth hormone (191 amino acids) — pharmaceutical somatropin exists for approved deficiency indications; research vials are a separate gray-market category.

C-terminal hGH fragment marketed for lipolysis; closely related to AOD-9604 discussions.

Urinary-derived or recombinant mixture of FSH and LH activity used in fertility medicine to stimulate gonadal function.

Mitochondrial-derived peptide studied for cytoprotection, metabolism, and neuroprotection.

Long-acting IGF-1 analog used in bodybuilding research circles for hypertrophy; significant risk profile.

Foundational peptide hormone for glucose control; abused in bodybuilding — extremely dangerous without medical need.

Selective ghrelin-receptor (GHS-R) agonist that stimulates GH with relatively clean side-effect profile among GHRPs.

Peptide that stimulates GnRH release; researched for reproductive endocrinology and low-libido / low-T workups.

Four-peptide recovery/aesthetic blend: KPV + BPC-157 + GHK-Cu + TB-500. Adds NF-κB-pathway anti-inflammatory KPV on top of the GLOW trio for deeper healing and inflammatory-control narratives.

Anti-inflammatory tripeptide fragment of alpha-MSH studied for gut and skin inflammation.

Quaternary ammonium compound that shuttles long-chain fatty acids into mitochondria for β-oxidation; injectable and oral forms used in metabolic and sports contexts.

Proprietary multi-ingredient injectable lipolytic cocktail marketed for localized fat reduction in aesthetic/mesotherapy practice (riboflavin, lecithin-related, and other components by source).

Classic lipotropic injectable blend (typically methionine, inositol, choline ± B vitamins/carnitine) used in weight-loss clinics as a metabolic adjunct.

Once-daily GLP-1 receptor agonist peptide with FDA-approved branded products for type 2 diabetes and chronic weight management; research vials are not those products.

Human antimicrobial peptide with immune and wound-related roles; experimental and potentially pro-inflammatory.

Palmitoylated pentapeptide widely used in cosmetic anti-aging formulations to stimulate collagen and extracellular-matrix remodeling signals.

Investigational oxyntomodulin-analog dual agonist of GLP-1 and glucagon receptors under late-stage development for obesity and metabolic disease.

Melanocortin analog; afamelanotide is approved for erythropoietic protoporphyria photoprotection — distinct from MT-II tan use.

Non-selective melanocortin agonist used illicitly for tanning and libido; notable side-effect profile.

Splice variant of IGF-1 expressed in response to mechanical overload; researched for localized muscle repair. Short half-life; PEGylated MGF is the stabilized catalog cousin.

Mitochondria-encoded peptide linked to exercise-mimetic metabolic regulation in research.

Not a peptide, but central to biohacking stacks often combined with mitochondrial peptides and clinic IVs.

Endogenous 28-amino-acid lateral-hypothalamic neuropeptide that preferentially activates OX2R to stabilize wakefulness, appetite, and arousal circuits.

Endogenous nonapeptide hormone for labor/lactation; researched for social bonding, anxiety, and intimacy.

Orally bioavailable CNTF-derived tetrapeptide (adamantylated) that enhances BDNF signaling, neurogenesis, and reduces tau/Aβ pathology in Alzheimer's mouse models.

Synthetic heptapeptide optimized from the natural sortilin-derived peptide spadin. Potent selective inhibitor of the TREK-1 (KCNK2) two-pore-domain potassium channel with preclinical antidepressant and neuroplasticity signals.

Pegylated mechano growth factor variant discussed for muscle repair; evidence mostly anecdotal/preclinical.

Short bioregulator peptide from the Khavinson group aimed at brain and pineal support.

Chimeric peptide combining a p53 HDM-2-binding segment with a membrane-penetration motif; studied for selective cancer cell membrane disruption in preclinical oncology research.

Melanocortin agonist approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women; also used off-label in men in clinics/forums.

Investigational triple agonist (GLP-1/GIP/glucagon) with very high weight-loss results in mid-stage trials.

Russian anxiolytic peptide analog of tuftsin; used for anxiety and cognitive stability without classic benzo sedation.

Long-acting GLP-1 receptor agonist; FDA-approved for type 2 diabetes and chronic weight management.

ACTH-derived nootropic peptide used in Russia for stroke and cognitive support; popular nasal nootropic abroad.

GHRH (1-29) analog historically used diagnostically and therapeutically to stimulate endogenous GH.

Experimental ERR agonist exercise-mimetic small molecule trending in biohacking; not a peptide.

Cosmetic octapeptide related to Argireline, designed to reduce expression lines by modulating SNARE-mediated neurotransmitter release in topical use.

Mitochondria-targeting tetrapeptide (elamipretide) studied for bioenergetic and rare disease indications.

Synthetic peptide related to thymosin beta-4, used in recovery communities for systemic tissue repair and flexibility.

FDA-approved GHRH analog for reducing excess abdominal fat in HIV-associated lipodystrophy; also discussed for visceral fat in biohacking circles.

Oral triple monoamine reuptake inhibitor (dopamine, norepinephrine, serotonin) studied for substantial weight loss; not a peptide but listed in oral research-capsule catalogs.

Thymic peptide preparation (and related thymulin nonapeptide) from the Khavinson/Russian thymic medicine tradition used for immunosenescence and immune reconstitution research.

Immune-modulating peptide used clinically in some countries for hepatitis and as an immune adjuvant.

Dual GIP/GLP-1 receptor agonist with strong clinical weight-loss and glycemic outcomes.

Long-acting GnRH superagonist that initially stimulates then downregulates pituitary gonadotropin release; used medically for hormone-dependent conditions.

Neuropeptide with vasodilatory and immunoregulatory roles; appears in mold-illness and pulmonary research discussions.

Community name for combining BPC-157 and TB-500 for soft-tissue and systemic recovery.

Small-molecule NNMT inhibitor often grouped with peptides in biohacking shops; metabolic research compound.